Effects of isoflavone-supplemented soy yogurt on lipid parameters and atherosclerosis development in hypercholesterolemic rabbits: A randomized double-blind study

Lipids in Health and Disease

Volumn 8, Issue , 2009, Pages

  Cavallini, Daniela Cu ^a   Abdalla, Dulcinéia Sp ^b   Vendramini, Regina C ^a   Bedani, Raquel ^a   Bomdespacho, Laura Q ^a   Pauly Silveira, Nadiége D ^a   De Valdez, Graciela F ^c   Rossi, Elizeu A ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c CENTRO DE REFERENCIA PARA LACTOBACILOS CERELA CONICET   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOFLAVONE; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; YOGHURT; ISOFLAVONE DERIVATIVE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENTEROCOCCUS FAECIUM; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; NONHUMAN; RABBIT; SOYBEAN; ANIMAL; BLOOD; CHEMISTRY; DIET THERAPY; DRUG EFFECT; LIPID METABOLISM; PATHOLOGY; RANDOMIZATION;

ANIMALIA; ENTEROCOCCUS FAECIUM; ORYCTOLAGUS CUNICULUS;

ANIMALS; ATHEROSCLEROSIS; CHOLESTEROL; CHOLESTEROL, LDL; ISOFLAVONES; LIPID METABOLISM; RABBITS; RANDOM ALLOCATION; SOYBEANS; YOGURT;

EID: 70449447665     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-8-40     Document Type: Article

References (47)

1. Inflammation and atherosclerosis. GK Hansson AK Robertson C Söderberg-Nauclér, Annu Rev Pathol 2006 1 297 329 10.1146/annurev.pathol.1.110304.100100 18039117
2. An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence. L Holme, Circulation 1990 82 1916 1924 2242517
3. The primary prevention of myocardial infarction. JE Manson H Tosteson PM Ridker S Satterfield P Herbert GT O'Conner, N Engl J Med 1992 336 1406 1416
4. Oxidized low-density lipoproteins, autoantibodies against oxidized low-density lipoproteins and carotid intima media thickness in a clinically healthy population. H-W Chen C-L Kuo C-S Huang S-J Kuo C-S Liu, Cardiology 2008 110 252 259 10.1159/000112409 18073481
5. Soy protein isolate reduces the oxidizability of LDL and the generation of oxidized LDL autoantibodies in rabbits with diet-induced atherosclerosis. NRT Damasceno G Hiro FMD Rodrigues CTS Dias FS Okawabata DSP Abdalla M Gidlund, J Nutr 2000 130 2641 2647 11053500
6. Inverse relation between levels of anti-oxidized-LDL antibodies and eicosapentanoic acid (EPA). L Garrido-Snchez E García-Fuentes G Rojo-Martínez F Cardona F Soringuer FJ Tinahones, Britsh J Nutr 2008 100 585 589
7. Low density lipoprotein undergoes oxidative modifications in vivo. W Palinski ME Rosenfeld S Yla-Herttuala GC Gurtner SS Socher SW Butler S Parthasarathy TE Carew D Steinberg JL Witztum, Proc Natl Acad Sci 1989 86 1372 1376 10.1073/pnas.86.4.1372 2465552
8. Oxidative modifications of LDL andatherogenesis. D Steinberg, Circulation 1997 95 1062 1071 9054771
9. Isoflavone aglycone-rich extract without soy protein attenuates atherosclerosis development in cholesterol-fed rabbits. J Yamakoshi MK Piskula T Izumi K Tobe M Saito S Kataoka A Obata M Kikuchi, J Nutr 2000 130 1887 1893 10917898
10. Effect of soy protein varying in isoflavone content on serum lipids in healthy young men. BL McVeigh BL Dillingham JW Lampe AM Duncan, Am J Clin Nutr 2006 83 244 251 16469981
11. Effects of Bacillus polyfermenticus SDC on lipid and antioxidant metabolism in rats fed a high-fat and high-cholesterol diet. H-D Paik JS Park E Park, Biol Pharm Bull 2005 28 1270 1274 10.1248/bpb.28.1270 15997112
12. Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers. JZ Xiao S Kondo N Takahashi K Miyaji K Oshida A Hiramatsu K Iwatsuki S Kokubo A Hosono, J Dairy Sci 2003 86 2452 2461 12906063
13. Effects of soybean isoflavones, probiotics, and their interactions on lipid metabolism and endocrine system in an animal model of obesity and diabetes. AA Ali MT Velasquez CT Hansen AI Mohamed SJ Bhathena, J Nutr Bichem 2004 15 583 590 10.1016/j.jnutbio.2004.04.005 (Pubitemid 39470212)
14. Dietary isoflavones in the prevention of cardiovascular disease A molecular perspective. G Rimbach C Boesch-Saadatmandi J Frank D Fuchs U Wenzel H Daniel WL Hall PD Weinberg, Food Chem Toxicol 2008 46 1308 1319 10.1016/j.fct.2007.06.029 17689850
15. - autoantibodies in experimental atherosclerosis. NRT Damasceno E Apolinrio FD Flauzino I Fernandes DSP Abdalla, Eur J Nutr 2007 46 125 132 10.1007/s00394-006-0640-9 17265172
16. In vitro effect of Enterococcus faecium and Lactobacillus acidophilus on cholesterol. EA Rossi GS Giori APR Holgado GF Valdez, Microbiologie-aliments- nutrition 1994 12 267 270
17. Development of a novel fermented soymilk product with potential probiotic properties. EA Rossi RC Vendramini IZ Carlos IC Pey GF Valdez, Eur Food Res Technol 1999 209 305 307 10.1007/s002170050499
18. Effects of a novel fermented soy product on the serum lipids of hypercholesterolemic rabbits. EA Rossi RC Vendramini IZ Carlos IS Ueiji M Squinzari SI Silva GF Valdez, Arq Bras Cardiol 2000 74 213 216 10.1590/S0066-782X2000000300003
19. Efeito de um novo produto fermentado de soja sobre lípides séricos de homens adultos normocolesterolmicos. EA Rossi CR Vendramini IZ Carlos MG Oliveira GF Valdez, Arch Latinoam Nutr 2003 53 47 51 12942871
20. Quantificaço de isoflavonas nas diversas etapas de processamento de "iogurte" de soja. EA Rossi I Rossier AR Dmaso IZ Carlos RC Vendramini DS Abdalla VH Talarico DF Minto, Alim Nutr 2004 15 93 99
21. Enzymatic determination of total serum cholesterol. CA Allain LS Poon CSG Chan W Richmond PC Fu, Clin Chem 1974 20 470 475 4818200
22. Methods of enzymatic analysis. HW Bergmeyer, London: Academic Press 1974 1890 1893
23. Serum triglycerides determined colorimetrically with an enzyme that produce hydrogen peroxide. P Fossati L Prencipe, Clin Chem 1982 29 2077 2080
24. Soy protein with or without isoflavones, soy germ and soy germ extract, and daidzein lessen plasma cholesterol levels in golden syrian hamsters. T Song S-O Lee PA Murphy S Hendrich, Exp Biol Med 2006 228 1063 1068
25. Joint Distribution of Non-HDL and LDL Cholesterol and Coronary Heart Disease Risk Prediction Among Individuals With and Without Diabetes. J Liu C Sempos RP Donahue J Dorn M Trevisan SM Grundy, Diabetes Care 2005 28 1916 1921 10.2337/diacare.28.8.1916 16043732
26. Etoposide treatment suppresses atherosclerotic plaque development in cholesterol-fed rabbits. M Llera-Moya GH Rothblat JM Glick JM England, Arterioscler Thromb 1992 12 1363 1370 1420096
27. Cholesterol-fed and casein-fed rabbit models of atherosclerosis. SJ Daley EE Herderick JF Cornhill KA Rogers, Arterioscler Thromb 1995 14 95 104
28. Effects of cholesterol diets on vascular function and atherogenesis in rabbits. Y-P Sun NC Lu WW Parmley CB Hollenbeck, PSEBM 2000 224 166 171 10.1046/j.1525-1373.2000.22416.x
29. Soy protein containing isoflavones reduces plasma concentration of lipids and lipoproteins. JR Crouse JG Terry TM Morgan BL McGill DH Davis T King JE Ellis GL Burke, Circulation 1998 97 816
30. Intake of isoflavone-supplemented soy yogurt fermented with Enterococcus faecium lowers serum total cholesterol and non-HDL cholesterol of hypercholesterolemic rats. EA Rossi DCU Cavallini IZ Carlos RC Vendramini AR Damaso GF Valdez, Eur Food Res Technol 2008 228 275 282 10.1007/s00217-008-0932- 9
31. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. WP Castelli RJ Garrison PW Wilson RD Abbott S Kalousdian WB Kannel, Jama 1986 256 2835 2838 10.1001/jama.256.20.2835 3773200
32. High density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. G Assmann H Schulte A von Eckardstein Y Huang, Atherosclerosis 1996 124 Suppl 11 S20 10.1016/0021-9150(96)05852-2 8831911
33. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) Study. AR Sharrett CM Ballantyne SA Coady G Heiss PD Sorlie D Catellier W Patsch, Circulation 2001 104 1108 1113 10.1161/hc3501.095214 11535564
34. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. DJ Gordon JL Probstfield RJ Garrison JD Neaton WP Castelli JD Knoke DR Jacobs Jr S Bangdiwala HA Tyroler, Circulation 1989 79 8 15 2642759
35. Cholesterol assimilation by lactic acid bacteria and bifidobacteria isolated from the human gut. DIA Pereira GR Gibson, Appl Environ Microbiol 2002 68 4689 4693 10.1128/AEM.68.9.4689-4693.2002 12200334
36. Progress in the effect of probiotics on cholesterol and its mechanism. JR Zhao H Yang, Wei Sheng Wu Xue Bao 2005 45 315 319 15989285
37. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. MS Anthony TB Clarkson CL Hughes TM Morgan GL Burke, J Nutr 1996 126 43 50 8558324
38. Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis on male cynomolgus monkeys. MS Anthony TB Clarkson BC Bullock JD Wagne, Arterioscler Thromb Vasc Biol 1997 17 2524 2531 9409223
39. Soy protein containing isoflavones reduces the size of atherosclerotic plaques without affecting coronary artery reactivity in adult male monkey. MR Adans DL Golden JK Williams AA Franke TC Register JR Kaplan, J Nutr 2005 135 2852 2856 16317131
40. Soy protein without isoflavones reduces aortic total and cholesterol ester concentrations greater than soy protein with isoflavones compared with casein in hypercholesterolemic hamsters. AW Wilson RJ Nicolosi T Kotyla B Fleckinger, Nutr Research 2007 27 498 504 10.1016/j.nutres.2007.05.005 (Pubitemid 47126671)
41. The role of natural antibodies in atherogenesis. P Shaw C Binder M Chang K Hartvigsen S Horkko Y Miller D Woelkers M Corr J Witztum, J Lipid Res 2005 46 1353 1363 10.1194/jlr.R500005-JLR200 15897601
42. Autoantibodies against oxidized low density lipoprotein: a review of clinical findings and assay methodology. W Craig, J Clin Lab Anal 1995 9 70 74 10.1002/jcla.1860090113 7722776
43. Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease. T Lehtimaki S Lehtinen T Solakivi, Thromb Vasc Biol 1999 19 23 27
44. Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL. C Bergmark R Wu U De Faire AK Lefvert J Swedenborg, Arteriscler Thromb Vasc Biol 1995 15 441 445
45. LDL oxidation in patients with severe carotid atherosclerosis: a study of in vitro and in vivo oxidation markers. E Maggi R Chiesa G Melissano R Castellano D Astore A Grossi G Finardi G Bellomo, Arteriscler Thromb 1994 14 1892 1899
46. Immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis. J Karvonen M Paivansalo YA Kesaniemi S Horkko, Circulation 2003 108 2107 2112 10.1161/01.CIR.0000092891.55157.A7 14530200
47. "Iogurte" de soja como coadjuvante no cancer de mama. FL Kinouchi, PhD thesis So Paulo State University, Clinical Analysis Department 2006